- Home
- PGY vs ALVO Comparison
PGY vs ALVO Comparison
Compare PGY & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGY | ALVO |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PGY | ALVO |
|---|---|---|
| Price | $21.85 | $5.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $39.86 | $9.25 |
| AVG Volume (30 Days) | ★ 2.5M | 647.7K |
| Earning Date | 02-12-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $1,245,946,000.00 | $573,350,000.00 |
| Revenue This Year | $28.75 | $20.85 |
| Revenue Next Year | $17.23 | $44.49 |
| P/E Ratio | ★ N/A | $22.03 |
| Revenue Growth | 28.33 | ★ 45.55 |
| 52 Week Low | $8.27 | $4.32 |
| 52 Week High | $44.99 | $13.70 |
Technical Indicators
Market Signals| Indicator | PGY | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 48.97 |
| Support Level | $22.72 | $4.79 |
| Resistance Level | $24.06 | $5.07 |
| Average True Range (ATR) | 1.31 | 0.33 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 16.63 | 53.39 |
Price Performance
Historical ComparisonAbout PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.